Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Contract research news in brief

October 13, 2009 Research and Development CRO

Pharmafocus' latest round-up of contract research news includes another CRO heading into private equity hands, changing requirements for the clinicaltrials.gov …
News

Head-to-head trial favours Shire’s Fosrenol

October 8, 2009 Research and Development, Sales and Marketing fosrenol, renal

Shire's Fosrenol could have a clinical advantage over rival drug Renagel from Genzyme, according to the results of what is …
News

GSK: Committed to improving UK clinical research

October 6, 2009 Research and Development GSK, GlaxoSmithKline, NHS

GSK is the second biggest pharma company in the world, and Britain’s biggest homegrown firm in the sector. That means …
Feature

Contract research news in brief

October 6, 2009 Research and Development CRO

Pharmafocus' periodic round-up of developments in the contract research sector includes contracts awarded to Inclinix, Foranep and Phase Forward and …
News

AZ signs biomarker research deal

October 5, 2009 Research and Development AZ, Cancer

A deal between AstraZeneca and Cancer Research UK is set to expand biomarker research into how new drugs behave in …
News

UK children recruited for H1N1 vaccine trials

October 2, 2009 Research and Development, Sales and Marketing h1n1, paediatric, vaccines

The UK has commenced a two-week swine flu vaccine trial, a month ahead of its planned programme to vaccinate 11 …
News

Quintiles opens Scottish central lab

September 28, 2009 Research and Development Quintiles, Scotland

Quintiles has opened new facilities near Edinburgh, Scotland, that more than double its ability to provide central laboratory services to …
News

Contract research news in brief

September 22, 2009 Research and Development CRO

Pharmafocus' periodic round-up of developments in the contract research sector includes an acquisition and alliance for BioClinica, accreditations for ICON …
News

Pfizer and Icagen extend pain drug deal

September 22, 2009 Research and Development Icagen, Pfizer

Pfizer has extended its existing deal with biotech Icagen, aimed at developing new treatments for pain and related disorders. Over …
News

AZ strikes drug development deal with Nektar Therapeutics

September 22, 2009 Research and Development AZ, Nektar

 AstraZeneca has licenced two anti-constipation drug development programmes from Nektar Therapeutics in a deal that could be worth more than …
News

Safety First

September 22, 2009 Research and Development, Sales and Marketing EU, US, reg, safety

A series of high-profile drug withdrawals in recent years has brought safety concerns to the fore, prompting more rigorous monitoring …
Feature

Renovo cuts jobs after takeover talks fail

September 18, 2009 Research and Development Renovo

UK biotech Renovo is planning to reduce its headcount by over a third after a takeover approach from an unnamed …
News

Merck’s osteoporosis candidate shows some promise in trials

September 16, 2009 Research and Development, Sales and Marketing Cancer, Merck

Merck & Co's investigational cathepsin K inhibitor odanacatib has shown some promise in a trial to treat osteoporosis in postmenopausal …
News

Conservatives leading on ‘industrial policy’ say CBI

September 16, 2009 Research and Development ABPI, hc, reform

 A change of government would benefit UK pharma, according to the Confederation of British Industry, which says the industry might …
News

Roche divests protein expression portfolio

September 10, 2009 Research and Development Roche, genomics

 Roche has sold its cell-free protein expression kits business for an undisclosed sum.Berlin-based company RiNA will take control of the …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026